How a beta-cell potassium channel links early too much insulin to later diabetes

KATP deficiency in hyperinsulinism and diabetes

NIH-funded research Washington University · NIH-11311343

This project looks at how loss of a specific potassium channel in insulin-making cells can first cause excess insulin and later lead to diabetes, with the goal of helping people with hyperinsulinism and diabetes.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWashington University NIH-funded
Lab location1 site (Saint Louis, United States)
Project IDNIH-11311343 on NIH RePORTER

What this research studies

Researchers will use laboratory models that can turn off the KATP channel in pancreatic beta cells to recreate the switch from excess insulin secretion to insulin deficiency. They will compare these inducible knockdown models with established type 2 diabetes models and measure electrical activity, calcium signals, and insulin release from beta cells. The work builds on genetic and animal evidence linking KATP defects to hyperinsulinism and neonatal diabetes, and uses new tools to probe timing and mechanisms of the crossover to secretory failure. The team aims to clarify why some patients progress from hyperinsulinism to long-term beta-cell decline and how treatments that open or close KATP channels might be used more safely.

Who could benefit from this research

Good fit: People with congenital hyperinsulinism, neonatal diabetes related to KATP mutations, or those with early hypersecretion that later fails would be most relevant to future related studies.

Not a fit: Patients whose diabetes arises from causes unrelated to beta-cell electrical signaling, or those needing immediate new therapies, are unlikely to receive direct benefit from this lab-focused project.

Why it matters

Potential benefit: If successful, this research could explain why some people with early hyperinsulinism later develop diabetes and help guide treatments that protect long-term insulin production.

How similar studies have performed: Previous genetic and animal research has shown that KATP channel defects cause abnormal insulin secretion and neonatal diabetes, but the specific progression from hyperinsulinism to later insulin failure is not well understood.

Where this research is happening

Saint Louis, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Adult-Onset Diabetes Mellitus
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.